The hierarchical management of antibacterial drugs is as follows:

1. "Unrestricted use" drugs (i.e. first-choice drugs, first-line drugs): good efficacy, small side effects, and low bacterial resistance. Low-cost antibacterial drugs can be used by clinical physicians at all levels according to their needs.

2. "Restricted use" drugs (i.e., second-choice drugs, second-line drugs): drugs that are effective but expensive or have certain limitations in toxic side effects and bacterial resistance. The reasons for their use must be explained. It can only be used with the consent and signature of the attending physician or above.

3. "Special use drugs" (i.e. third-line drugs): good efficacy, expensive, there is still little clinical data on the efficacy or safety of special drug-resistant bacteria or newly launched antibacterial drugs, or clinical needs Drugs that are designed to double protect bacteria from developing drug resistance too quickly should have strict indications or solid basis for use. They must be consulted by relevant experts or approved by the undergraduate director, and their prescriptions must be signed by the deputy director and chief physician before they can be used.

4. Our hospital’s “Antimicrobial Drug Hierarchical Management Catalog” covers all antibacterial drugs. When new drugs are introduced, their hierarchical management levels should be clarified at the same time.

Expand knowledge

1. The Pharmaceutical Affairs Management Committee, the Pharmacy Department and the Medical Department regularly carry out training and education on rational drug use, and supervise the clinical rational use of drugs in our hospital; in accordance with the "Guiding Principles" and The "Implementation Rules" stipulate regular and irregular supervision and inspection of the use of antibacterial drugs in various departments, and provide correction and improvement suggestions for irrational drug use.

2. Incorporate the rational use of antimicrobial drugs into the medical quality inspection content and the department’s comprehensive target management assessment system.

3. Inspection and assessment methods: Regular random inspections of outpatient and emergency prescriptions, inpatient medical records, including the preventive use of antibacterial drugs in surgical patients.

IV. Key points for the examination and assessment of antimicrobial drugs in outpatient and emergency departments: writing the patient’s basic information, including age, gender, and diagnosis; the use of antimicrobial drugs, including name, specifications, usage, dosage, route of administration, and whether The hierarchical management of antibacterial drugs regulates the use of drugs, etc.

5. Whether the reasons are analyzed and explained when antibacterial drugs are started, stopped, changed varieties, or used beyond the scope of the instructions, and recorded in the disease course record;